Compare ZNTL & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZNTL | GHI |
|---|---|---|
| Founded | 2014 | 1998 |
| Country | United States | United States |
| Employees | N/A | 5 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 156.7M | 173.3M |
| IPO Year | 2020 | 1998 |
| Metric | ZNTL | GHI |
|---|---|---|
| Price | $2.85 | $7.35 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $6.60 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 653.4K | 55.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 20.14% |
| EPS Growth | ★ 47.87 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $67,425,000.00 | ★ $91,271,399.00 |
| Revenue This Year | N/A | $201.02 |
| Revenue Next Year | N/A | $2.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.01 | $6.01 |
| 52 Week High | $3.95 | $13.29 |
| Indicator | ZNTL | GHI |
|---|---|---|
| Relative Strength Index (RSI) | 58.12 | 41.31 |
| Support Level | $1.29 | $6.41 |
| Resistance Level | $3.95 | $7.50 |
| Average True Range (ATR) | 0.22 | 0.24 |
| MACD | 0.06 | -0.06 |
| Stochastic Oscillator | 61.58 | 14.81 |
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.